Target Price | $74.46 |
Price | $67.18 |
Potential | 10.84% |
Number of Estimates | 31 |
31 Analysts have issued a price target Mondelez International 2026 . The average Mondelez International target price is $74.46. This is 10.84% higher than the current stock price. The highest price target is $85.05 26.60% , the lowest is $58.58 12.80% . | |
A rating was issued by 35 analysts: 24 Analysts recommend Mondelez International to buy, 10 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Mondelez International stock has an average upside potential 2026 of 10.84% . Most analysts recommend the Mondelez International stock at Purchase. |
28 Analysts have issued a sales forecast Mondelez International 2025 . The average Mondelez International sales estimate is $39.1b . This is 7.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $40.9b 12.14% , the lowest is $36.8b 0.86% .
This results in the following potential growth metrics:
2024 | $36.4b | 1.18% |
---|---|---|
2025 | $39.1b | 7.36% |
2026 | $40.8b | 4.27% |
2027 | $42.4b | 3.88% |
2028 | $43.5b | 2.71% |
2029 | $45.6b | 4.74% |
2030 | $47.1b | 3.23% |
2031 | $48.9b | 3.87% |
2032 | $50.9b | 4.22% |
26 Analysts have issued an Mondelez International EBITDA forecast 2025. The average Mondelez International EBITDA estimate is $6.9b . This is 44.06% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.3b 52.66% , the lowest is $6.4b 35.63% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.8b | 16.88% |
---|---|---|
2025 | $6.9b | 0.01% |
2026 | $7.5b | 9.07% |
2027 | $7.8b | 4.03% |
2028 | $7.5b | 4.08% |
2029 | $9.3b | 24.55% |
2030 | $9.7b | 4.21% |
2031 | $10.2b | 5.11% |
2032 | $10.7b | 4.94% |
2024 | 18.79% | 15.51% |
---|---|---|
2025 | 17.51% | 6.84% |
2026 | 18.31% | 4.57% |
2027 | 18.34% | 0.16% |
2028 | 17.13% | 6.60% |
2029 | 20.37% | 18.91% |
2030 | 20.56% | 0.93% |
2031 | 20.81% | 1.22% |
2032 | 20.95% | 0.67% |
29 Mondelez International Analysts have issued a net profit forecast 2025. The average Mondelez International net profit estimate is $4.0b . This is 10.58% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.1b 14.78% , the lowest is $3.8b 5.01% .
This results in the following potential growth metrics and future Net Margins:
2024 | $4.6b | 7.02% |
---|---|---|
2025 | $4.0b | 13.64% |
2026 | $4.4b | 9.99% |
2027 | $4.8b | 9.75% |
2028 | $5.1b | 6.62% |
2029 | $5.7b | 10.79% |
2030 | $6.2b | 9.32% |
2031 | $6.7b | 8.51% |
2032 | $7.3b | 8.63% |
2024 | 12.65% | 8.10% |
---|---|---|
2025 | 10.18% | 19.55% |
2026 | 10.74% | 5.50% |
2027 | 11.34% | 5.59% |
2028 | 11.78% | 3.88% |
2029 | 12.46% | 5.77% |
2030 | 13.19% | 5.86% |
2031 | 13.78% | 4.47% |
2032 | 14.36% | 4.21% |
29 Analysts have issued a Mondelez International forecast for earnings per share. The average Mondelez International EPS is $3.08 . This is 12.00% higher than earnings per share in the financial year 2024. The highest EPS forecast is $3.19 16.00% , the lowest is $2.92 6.18% .
This results in the following potential growth metrics and future valuations:
2024 | $3.42 | 5.52% |
---|---|---|
2025 | $3.08 | 9.94% |
2026 | $3.38 | 9.74% |
2027 | $3.71 | 9.76% |
2028 | $3.96 | 6.74% |
2029 | $4.39 | 10.86% |
2030 | $4.79 | 9.11% |
2031 | $5.20 | 8.56% |
2032 | $5.65 | 8.65% |
Current | 24.43 | 6.50% |
---|---|---|
2025 | 21.85 | 10.56% |
2026 | 19.86 | 9.11% |
2027 | 18.10 | 8.86% |
2028 | 16.97 | 6.24% |
2029 | 15.32 | 9.72% |
2030 | 14.01 | 8.55% |
2031 | 12.91 | 7.85% |
2032 | 11.89 | 7.90% |
Based on analysts' sales estimates for 2025, the Mondelez International stock is valued at an EV/Sales of 2.68 and an P/S ratio of 2.22 .
This results in the following potential growth metrics and future valuations:
Current | 2.88 | 4.32% |
---|---|---|
2025 | 2.68 | 6.84% |
2026 | 2.57 | 4.10% |
2027 | 2.48 | 3.73% |
2028 | 2.41 | 2.64% |
2029 | 2.30 | 4.52% |
2030 | 2.23 | 3.13% |
2031 | 2.15 | 3.73% |
2032 | 2.06 | 4.05% |
Current | 2.39 | 4.48% |
---|---|---|
2025 | 2.22 | 6.80% |
2026 | 2.13 | 4.09% |
2027 | 2.05 | 3.73% |
2028 | 2.00 | 2.64% |
2029 | 1.91 | 4.52% |
2030 | 1.85 | 3.13% |
2031 | 1.78 | 3.72% |
2032 | 1.71 | 4.05% |
Mondelez International...
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Equal-Weight
➜
Overweight
|
Upgrade | Jun 20 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 01 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 30 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 28 2025 |
DA Davidson |
Buy
➜
Neutral
|
Downgrade | Apr 24 2025 |
Analyst Rating | Date |
---|---|
Upgrade
Wells Fargo:
Equal-Weight
➜
Overweight
|
Jun 20 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 01 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 30 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 30 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 28 2025 |
Downgrade
DA Davidson:
Buy
➜
Neutral
|
Apr 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.